The therapeutic properties of plasminogen activators are dictated by their mechanism of action. Unlike staphylokinase, a single domain protein, streptokinase, a 3-domain (␣, ␤, and ␥) molecule, nonproteolytically activates human (h)-plasminogen and protects plasmin from inactivation by ␣ 2 -antiplasmin. Because a streptokinase-like mechanism was hypothesized to require the streptokinase ␥؊domain, we examined the mechanism of action of a novel two-domain (␣,␤) Streptococcus uberis plasminogen activator (SUPA). Under conditions that quench trace plasmin, SUPA nonproteolytically generated an active site in bovine (b)-plasminogen. SUPA also competitively inhibited the inactivation of plasmin by ␣ 2 -antiplasmin. Still, the lag phase in active site generation and plasminogen activation by SUPA was at least 5-fold longer than that of streptokinase. Recombinant streptokinase ␥-domain bound to the b-plasminogen⅐SUPA complex and significantly reduced these lag phases. The SUPA-b⅐plasmin complex activated b-plasminogen with kinetic parameters comparable to those of streptokinase for h-plasminogen. The SUPA-b⅐plasmin complex also activated h-plasminogen but with a lower k cat (25-fold) and k cat /K m (7.9-fold) than SK. We conclude that a ␥-domain is not required for a streptokinase-like activation of b-plasminogen. However, the streptokinase ␥-domain enhances the rates of active site formation in b-plasminogen and this enhancing effect may be required for efficient activation of plasminogen from other species.
with plasmin (1) (2) (3) (4) . In this complex, SK or SAK serves as a cofactor that redirects the substrate specificity of plasmin from the cleavage of fibrin to the cleavage of Pg. Despite their similarities, SAK and SK have fundamentally different mechanisms. SK binds with significantly greater affinity to plasmin than SAK (5) . The SAK⅐plasmin complex, but not the SK⅐plasmin complex is inactivated by ␣ 2 -antiplasmin, the serine protease inhibitor of plasmin (2, 6) . Among all of the Pg activators, SK has the unique ability to bind and nonproteolytically generate an active site in the Pg zymogen (i.e. convert Pg to Pg*) (7) (8) (9) .
The mechanism by which SK nonproteolytically generates an active site in the zymogen Pg (Pg*) is controversial (10 -12) . Clues to this mechanism have come from comparisons of the structures of SK and SAK (13) . SK has three sequential domains of roughly equal sizes (␣, ␤, and ␥) linked by flexible loops (11) . The SK ␥-domain binds near the autolysis loop of plasmin (11) . On the basis of studies with recombinant (r) fragments Young et al. (10) concluded that the carboxyl terminus of SK (including all of ␥-domain) induced a conformational change in the active center of Pg leading to nonproteolytic activation of the molecule, a process that has been dubbed "binding or contact activation (13) ." By analogy to the activation of tissue Pg activator, which has significantly greater activity as a zymogen than Pg, it has been suggested that the binding of ␥-domain to the autolysis loop of Pg induces the formation of a critical intramolecular salt bridge between Lys 698 and Asp 740 of Pg that productively structures the activation domain (11) . Another hypothesis ("molecular sexuality") states that SK nonproteolytically activates Pg when the NH 2 -terminal isoleucine-1 (Ile 1 ) of the ␣-domain forms a salt bridge with Asp 740 of Pg (12) . In this activation sequence, which is typical of the zymogens of the chymotrypsinogen family, salt bridge formation productively restructures the latent activation domain (14) . Either mechanism, "␥-domain contact activation" or molecular sexuality, is plausible given the current structural information for the microplasmin⅐SK complex (13) .
Novel insights into the structural elements required for a staphylokinase versus a streptokinase mechanism of Pg activation may come from an analysis of a recently isolated Streptococcus uberis Pg activator (SUPA, also known as PauA) (15) . SUPA is produced by a streptococcus that causes mastitis in cows and has no significant nucleotide or genomic homology to streptokinase or staphylokinase (16, 17) . SUPA has a putative two-domain structure (29 kDa) that is intermediate between the one-domain structure of SAK (16 kDa) and the threedomain structure of SK (47 kDa). SUPA has been considered a new class of bacterial Pg activator that may act through a unique mechanism (16, 17) with Pg activation kinetics similar to streptokinase and a staphylokinase-like susceptibility to inhibition by ␣ 2 -antiplasmin (18) . In this study we have investigated the properties of the activator complex formed by SUPA and bovine Pg to determine the structural elements required for nonproteolytic active site generation and for rendering the activator complex resistant to inhibitors such as ␣ 2 -antiplasmin.
EXPERIMENTAL PROCEDURES
Protein and Reagents--Bovine (b) Pg was prepared from fresh citrated b-plasma by affinity chromatography with lysine-substituted Sepharose and pretreated with aprotinin-agarose to remove contaminating plasmin (19) . The purified b-Pg was assessed by 10% SDS-PAGE and active site titration after activation by urokinase (9 nM, 1 h at 37°C, in 50 mM Tris buffer, 0.15 M NaCl, 20% glycerol) as described (5) . The b-Pg contained less than 0.5% plasmin.
Cloning, Expression, and Purification of Recombinant (r) ProteinsThe SK gene was cloned from Streptococcus equisimilis, expressed in bacteria as a MBP fusion protein via the pMalc vector (New England Biolabs, Beverly, MA), and purified as described in detail (5) . The ␥-domain of SK (residues 293-414) was cloned using the full-length cDNA of SK and the corresponding primers (5Ј sense primer catcagctgttcaccatcaaatacgttg, PvuII; 3Ј antisense primer gcctgcagtcattatttgtcgttagg, PstI). After double-stranded DNA sequencing it was ligated into pMALc vector at StuI and PstI sites. The SK ␥-domain fusion protein was purified by affinity chromatography on an amylose resin (New England Biolabs) and its purity was assessed by SDS-PAGE.
Eleven strains of Streptococcus uberis were tested for their ability to activate b-Pg. Genomic DNA was isolated as described (20) . Polymerase chain reaction was performed with primers containing EcoRV and HindIII 5Ј-gatatcaccggttaygaywsngaytaytaygc and tctagattaaggtttataacttttyttngtdatnarrtayttytc. The amplified DNA from SUPA clone 70.2 was sequenced on both strands and ligated into the pMal-c vector (New England Biolabs) at the StuI site for expression as a fusion polypeptide with maltose-binding protein (MBP). Cloning at this site permits specific cleavage between MBP and Ile 1 of SUPA, yielding intact SUPA with its native NH 2 terminus (12). The MBP-rSUPA fusion protein was absorbed on DEAE Affi-Gel Blue-agarose and eluted between 110 and 150 mM NaCl by a linear gradient of 0 to 200 mM NaCl in 10 mM phosphate buffer, pH 7.2. The rSUPA was cleaved from MBP by treatment with Factor Xa (New England Biolabs) for 24 h at room temperature in 200 mM Tris-HCl buffer, pH 8.0, 100 mM NaCl, 2 mM CaCl 2 . The SUPA cDNA 70.2 was also subcloned into pProEX HTb expression vector (Life Technologies) using BamHI and PstI restriction enzymes. This resulted in the expression of SUPA with a short N-terminal fusion peptide containing a His 6 -tag. The His 6 -SUPA protein was absorbed on Ni-NTA affinity resin and eluted by 20 mM Tris-HCl, pH 8.5 (at 4°C), with 100 mM KCl, 5 mM 2-mercaptoethanol, 10% glycerol, and 100 mM imidazole. The eluted sample was analyzed by SDS-PAGE and dialyzed against assay buffer (50 mM Tris-HCl, 100 mM NaCl, pH 7.4).
Active Site Titration-The molar quantity of active sites generated by rSUPA in b-Pg was determined by active site titration with the fluorogenic substrate 4-methylumbelliferyl p-guanidinobenzoate (MUGB, Sigma) as described (5, 21) .
Kinetic Assays-The amidase kinetic parameters of human plasmin (h-plasmin), b-plasmin, and the activator complexes were studied with H-D-valyl-L-leucyl-L-lysine-p-nitroanilide dihydrochloride (S2251, Chromogenix, Sweden) as previously described (22) . The h-plasmin⅐rSK and b-plasmin⅐rSUPA complexes were prepared by mixing 10 nM h-Pg (Ն95% Glu-Pg; Chromogenix, Sweden) or b-Pg with 20 nM rSK or rSUPA for 5 min at 37°C. The h-plasmin⅐rSUPA complex was formed by mixing 10 nM h-plasmin (Sigma) and 20 nM rSUPA for 10 min on ice. The enzymes were transferred to a thermostatically regulated (37°C) quartz cuvette containing assay buffer (50 mM Tris-HCl, 100 mM NaCl, pH7.4) and various concentrations of S2251 (80 -800 M) in a total volume of 300 l and the change in absorbance was monitored at 405 nm for 5 min in a Cary 100-Bio spectrophotometer. Less than 10% of H-D-Val-Leu-Lys-nitroanilide was consumed during the course of the reaction. The data were plotted as V/S and analyzed by hyperbolic curve fitting with the Sigma Plot program. An ⑀ 1 M at 405 nm of 10,000 was used for p-nitroanilide.
Steady-state Pg Activation Kinetic Parameters-The kinetics of Pg activation by either free rSK and rSUPA or activator complexes were studied as described (23) . Stoichiometric activator complexes were formed by mixing h-Pg (Ն95% Glu-Pg; Chromogenix, Sweden) and rSK or b-Pg and rSUPA on ice for 30 min. The stoichiometric h-plasmin⅐rSUPA activator complex was formed at 37°C for 5 min. Activators were added to a quartz cuvette containing assay buffer, 0.5 mM S2251, and Pg (50 -900 nM) in a total volume of 300 l at 37°C as described. Initial reaction rates were obtained from the first 300 s by plotting A 405 /min 2 , and the apparent Michaelis and catalytic rate constants were calculated by fitting the data to a hyperbolic curve as described (23) using the Sigma Plot program.
Continuous Assay for Determination of the Rates of Active Site Generation in Pg-SK Complexes-The first-order rate constant for the appearance of an amidolytic active center in the hPg⅐SK complex was determined as described by Chibber and Castellino (24) at 4°C, in a final volume of 0.3 ml, with a low ionic strength buffer consisting of 10 mM Hepes/NaOH, pH 7.4. Then h-Pg (100 nM; Ն95% Glu-Pg; Chromogenix, Sweden) or b-Pg (300 nM; Յ0.5% plasmin) was added to a cuvette in the presence of 0.5 mM S2251. After incubation for 5 min at 4°C, native SK (100 nM, Sigma) or rSUPA (300 nM) was added, and the release of p-nitroanilide was monitored. The rate constant for active site appearance (k) was measured as described (24) by the equation:
) and was essentially constant because substrate depletion was Յ10%.
Binding Assays-Wells of microtiter plate were coated with 50 l of b-Pg (5 g/ml). The wells were washed and nonspecific protein-binding sites were blocked with 1% bovine serum albumin. After that 50 l of rSUPA (50 g/ml) were added for 1 h. After washing 50 l of SK ␥-domain (0 -50 g/ml) or MPB (0 -50 g/ml) were added. After a 1-h incubation and washing, anti-MBP monoclonal antibody was added for 1 h. After washing bound antibody was detected by 125 I-goat anti-mouse antibody (50,000 cpm) followed by ␥-counting.
Influence of SUPA on the Bovine Plasmin-␣ 2 -Antiplasmin reaction kinetic measurements were carried out in a 1-ml cuvette in filtered, dust-free assay buffer (50 mM Tris, 100 mM NaCl, pH 7.4) at 37°C using a thermostatted Cary 100-Bio spectrophotometer. The rate constant k 1 of the reaction between b-plasmin and ␣ 2 -antiplasmin was measured as described (6) . Briefly b-plasmin (14 nM) was added to cuvettes containing S2251 (500 nM), SUPA (0 -500 nM), and the change in absorbance at 405 nm recorded for 90 s prior to the addition of human ␣ 2 -antiplasmin (Calbiochem; 90 nM). The residual enzyme activity was measured by the first derivative (dA/dt) of the curve before 60% of the enzyme was inactivated. The apparent rate constant (k 1, app ) of the inhibition of the enzyme activity by ␣ 2 -antiplasmin in the presence of various concentrations of SUPA was calculated from the classical second-order rate equation as described (6) .
RESULTS
Primary Structure of SUPA-The lysates of 11 b-isolates of S. uberis were tested for their ability to activate b-Pg. The SUPA gene was cloned from the S. uberis isolate (number 70) that showed the greatest Pg activation. The deduced amino acid sequence predicted a mature peptide mass of 30.7 kDa (GenBank TM accession number AF283574). In pairwise alignments by ClustalW (Table I) , the putative ␣-domain of SUPA showed 11.9% identity with SAK, 30.9% with SK ␣, 10.3% with SUPA ␤, 16.7% with SK ␤, and 9.5% with SK ␥ (25). The SUPA ␤-domain showed 11.9% identity with SK ␣, 15.6% with SAK, 27.4% with SK ␤, and 12.2% with SK ␥. By comparison, SAK showed 17.7% identity with SK ␣, 14% with SK ␤, and 20.6% with SK ␥. In contrast to previous reports, a comparison of the three sequences by ClustalW (Fig. 1) showed that SUPA contained an Ile-Thr-Gly terminus which is similar to the Ile-AlaGly sequence that has been suggested to mediate nonproteolytic activation of Pg by SK (12, 16, 17 ). In the crystal structure SK ␣Ϫdomain residues Glu 39 and Glu 134 form salt bridges with (29) . Active Site Generation-A critical distinction between a SAK and SK mechanism is the ability of SK to generate an active site in Pg under conditions in which proteolysis is blocked. Consequently, the ability of SUPA to generate an active site generation in b-Pg was studied in the presence of a titrant (MUBG) that rapidly acylates the active site of plasmin, as originally described by McClintock and Bell (7) . Under these conditions trace plasmin is rapidly inactivated and SK, but not SAK, can generate an active site in Pg. When b-Pg was added to the active site titrant only minimal numbers of preformed active sites were detected ( Fig. 2A) indicating that only trace quantities of plasmin were present in this preparation (21) . When b-Pg was preincubated with MUGB for 5 min (to inhibit trace amounts of plasmin), followed by the addition of His 6 -rSUPA or MBP-rSUPA minimal active site generation occurred (ϳ5-12% of expected). However, when rSUPA was added 5 min after b-Pg to the cuvette, there was rapid and complete active site formation. Examination of the reaction between SUPA and b-Pg by SDS-PAGE showed that active site generation occurred in the b-Pg molecule without proteolytic generation of plasmin (Fig. 2B) . Thus SUPA, like SK but not SAK (3), nonproteolytically generated an active site in b-Pg. However, rSUPA was unable to generate an active site in h-Pg and rSK could not generate one in b-Pg (Fig. 4B and not shown) .
Temperature Dependence and Rate of Active Site Formation-When compared with rSK and h-Pg under similar conditions, active site generation in b-Pg by rSUPA was slower ( Fig.  2A) and rSUPA also required a higher reaction temperature (19°C) than SK (4°C) for any active site generation to be detected (not shown). Similarly, when rSUPA was added to b-Pg it generated an amidolytic active site with a rate constant of 0.18 min Ϫ1 while rSK generated an active site in h-Pg with a rate of 0.55 min Ϫ1 at 4°C (data not shown). In Pg activation studies, rSUPA showed a greater delay or lag than rSK in the development of plasmin generation. For example, at 37°C the delay or lag phase before the onset of Pg activation by rSUPA was Ͼ5-fold longer than rSK (Fig. 3) . Pg activation by rSUPA was more temperature-dependent than rSK (Fig. 3) , the lag phase for Pg activation by rSUPA lengthened twice as much as rSK for every degree drop in reaction temperature. To determine whether the lag phase in the onset of b-Pg activation by rSUPA was related in part to its lack of a ␥-domain, we examined the effects of MBP-␥-domain of SK or MBP alone on b-Pg activation by rSUPA (Fig. 4) . Binding experiments confirmed that the MBP-SK ␥-domain, but not MBP alone bound to the formed SUPA⅐b-Pg complex (Fig. 4A) . In activation experiments, the MBP-␥-domain reduced the lag phase in b-Pg activation by rSUPA by about half (from ϳ10 to 5 min) while MBP or catalytic amounts of rSK had no effect (Fig. 4B ). Additional active site titration studies were performed to determine whether this reduced "lag phase" in Pg activation induced by the ␥-domain was due to an acceleration of active site exposure in the b-Pg⅐rSUPA complex. When compared with MBP as a control, the MBP-␥-domain reduced the time necessary for active site generation by rSUPA in b-Pg (from ϳ240 to 120 s; Fig. 4C) .
Influence of rSUPA on the b-Plasmin/␣ 2 -Antiplasmin Reaction-Another property that distinguishes SK from SAK is the resistance of the SK activator complex to inhibition by ␣ 2 -antiplasmin (2, 6). The second-order rate constant (k 1 ) for inhibition of plasmin by ␣ 2 -antiplasmin was 3.15 Ϯ 0.61 ϫ 10
. Increasing concentrations of rSUPA inhibited the inactivation of b-plasmin (14 nM) by an excess of ␣ 2 -antiplasmin (90 nM) in a dose-dependent fashion, with a 50% reduction seen at a concentration of ϳ30 nM rSUPA (Fig. 5) .
Steady State Amidase Parameters and Kinetics of Pg Activation-In amidolysis assays h-plasmin and h-plasmin-SK
showed similar catalytic parameters (Table II) . However, the catalytic efficiency (k cat /K m ) of b-plasmin-rSUPA was 3.6-fold less than free b-plasmin. This difference was largely due to a 2.8-fold increase in the K m for amidolysis when rSUPA was bound to plasmin. The b-plasmin⅐SUPA complex was 2.9-fold less efficient (k cat /K m ) in amidolysis than the h-plasmin⅐SK complex because of a slightly higher K m and lower k cat .
The b-Pg⅐rSUPA complex and free rSUPA showed similar kinetic parameters for Pg activation (Table III) . The h-Pg⅐SK complex was slightly more catalytically efficient (2-fold) as an activator of h-Pg than the b-plasmin⅐rSUPA complex was as an activator of b-Pg, largely because of a lower K m (1.7-fold). The b-plasmin⅐SUPA complex also activated h-Pg, but was 7.9-fold less efficient than h-Pg-rSK, chiefly because of a 25-fold lower k cat .
DISCUSSION
The unique amino acid and genomic structure of SUPA had suggested that it activated Pg through a different mechanism (16, 17) with properties typical of both SAK and SK (18) . However, in the presence of plasmin, SAK and SK mechanisms are indistinguishable (12) . In the present experiments, active site generation by SUPA was examined under classical experimental conditions where excess acylating agent was present to inhibit trace amounts of plasmin (7, 8) . These studies indicate that SUPA nonproteolytically activates b-Pg through a SK-and not a SAK-type of mechanism. Moreover, like the SK activator complex, and unlike the SAK⅐plasmin complex, the SUPA activator complex resists inactivation by ␣ 2 -antiplasmin. These findings indicate that for the activation of b-Pg by SUPA, a ␥Ϫdomain is not required for a SK-type of mechanism.
The b-plasmin⅐SUPA complex activates b-Pg with kinetic parameters that resemble (within a factor of 3) the parameters of Pg⅐SK for h-Pg activation. When compared with the h-plasmin⅐SK complex, the b-plasmin⅐SUPA complex showed comparable kinetics for amidolysis with a slightly higher K m (1.8-fold) and lower k cat (1.7-fold). Although SUPA could not generate an active site in h-Pg, the b-plasmin⅐SUPA complex (12) . Mutagenesis studies aimed at identifying the counterion have indicated that Ile 1 is required for nonproteolytic activation of Pg, while Lys 698 appears to be required for normal binding interactions during the formation of the initial SK⅐Pg complex (12, 31) . The conservation of the NH 2 -terminal motif (Ile-Xxx-Gly) between SUPA and all other reported SKs underlines the importance of this residue (12) . As predicted by studies of SK, efficient active site generation in b-Pg in the presence of an acylating agent only occurred when the Ile 1 of SUPA was free and not when it was tethered in fusion proteins.
What role does the ␥-domain play if SUPA can activate b-Pg nonproteolytically, protect b-plasmin from inhibition from by ␣ 2 -antiplasmin, and form an activator complex that cleaves different species Pgs? The ␥-domain is found in streptokinases isolated from humans, pigs, and horses suggesting that there is an evolutionary pressure to maintain it which may relate to the fact that there are species differences in the structural requirements for Pg activation. When compared with SK, SUPA generated an active site more slowly in b-Pg and required higher ambient temperatures for function. Exogenous ␥-domain bound to the SUPA activator complex and accelerated the process of active site formation, suggesting that the ␥-domain may serve as an enhancer of these processes, perhaps through its interactions with the autolysis loop of b-Pg (which is 88% identical to h-Pg (32)). Although this enhancer function is not required by b-Pg, it appears to be required by human Pg, because a SUPA-like mutant of SK lacking the ␥-domain is unable to activate human Pg. 2 Analyses of the crystal structures of Pg have indicated that generation of a functional active site requires several intramolecular rearrangements that may be facilitated by interactions with the ␥-domain (32, 33 
